tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
ELVN
Enliven Therapeutics
RESEARCH TOOLSreports

Enliven Therapeutics (ELVN) Cash flow

331 Followers

Enliven Therapeutics Cash Flow

ELVN's free cash flow for Q4 2025 was $-15.84M. For the 2025 fiscal year, ELVN's free cash flow was decreased by $2.78M and operating cash flow was $-15.84M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -70.30M$ -73.19M$ -61.27M$ -32.08M$ -19.13M
Investing Cash Flow
$ -173.84M$ -36.00M$ -148.41M$ -612.00K$ -191.00K
Financing Cash Flow
$ 218.87M$ 133.16M$ 234.29M$ -1.80M$ -1.02M
End Cash Position
$ 98.90M$ 124.17M$ 100.19M$ 75.59M$ 110.08M
Free Cash Flow
$ -70.46M$ -73.24M$ -61.42M$ -32.69M$ -19.32M
Currency in USD

Enliven Therapeutics Cash Flow